secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amneal Pharmaceuticals, Inc. (AMRX)
CIK:        0001723128
Form:       8-K/A
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001193125-23-296632
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amneal files corrected bylaws as part of 8-K/A amendment to prior merger filing
-------------------------------------------------------------------------------

- Amendment No.1 corrects Exhibit 3.2 (Amended and Restated Bylaws) from Nov 7, 2023 merger.
- No other changes from original 8-K; all other exhibits remain unchanged.
- Original 8-K reported merger agreements and related amendments to employment and governance documents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723128/000119312523296632/0001193125-23-296632-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723128/000119312523296632/d66330d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-296632

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer